Literature DB >> 4626940

Optimal intravesical dosage of thio-tepa in the prophylaxis of recurrent bladder papillomatosis.

K J Oravisto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4626940     DOI： 10.3109/00365597209132075

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN： 0036-5599


× No keyword cloud information.
  2 in total

1.  The prophylactic use of Thio-TEPA, an adjuvant in the treatment of bladder tumours.

Authors:  W Dobrzecki; A Kaczmarek
Journal:  Int Urol Nephrol       Date:  1977       Impact factor: 2.370

Review 2.  Intravesical chemotherapy in the United States. An overview.

Authors:  J T Spaulding
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.